- Home
- HUMA vs NUW Comparison
HUMA vs NUW Comparison
Compare HUMA & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUMA | NUW |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.6M | 256.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HUMA | NUW |
|---|---|---|
| Price | $1.06 | $14.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $10.13 | N/A |
| AVG Volume (30 Days) | ★ 4.9M | 45.3K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.66% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,571,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $698.97 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.91 | $12.45 |
| 52 Week High | $5.48 | $14.44 |
Technical Indicators
Market Signals| Indicator | HUMA | NUW |
|---|---|---|
| Relative Strength Index (RSI) | 41.80 | 50.38 |
| Support Level | $0.91 | $14.27 |
| Resistance Level | $1.17 | $14.43 |
| Average True Range (ATR) | 0.08 | 0.13 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 38.46 | 57.14 |
Price Performance
Historical ComparisonAbout HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About NUW Nuveen AMT-Free Municipal Value Fund
Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations. The fund predominantly invests in long-term municipal bonds, corporate bonds, short-term municipal bonds, and other assets.